Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
N-[[4-[2-[[4-(2-Butyn-1-yloxy)phenyl]sulfonyl]-1-(formylhydroxyamino)ethyl]phenyl]methyl]methanesulfonamide was used to study components containing ADAM17-inhibiting N-hydroxyformamide derivatives for maintaining platelet functions in cultures. The compound was also used in the study to prepare N-hydrooxyformamides as ADAM inhibitors for treatment of various diseases.